You are here: Industry Insights > INDICAID

News List

INDICAID(TM) COVID-19 Rapid Antigen Test Receives Emergency Use Authorization From the U.S. Food and Drug Administration prnasia
August 11, 2021
PHASE Scientific International LTD (PHASE Scientific), today announced that its INDICAID™ COVID-19 Rapid Antigen Test (INDICAID) received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) on July 29, 2021.
INDICAID(R) COVID-19 Rapid Antigen Test certified by Cambodia's Ministry of Health for Disease Control prnasia
June 22, 2021
Cambodia's Ministry of Health has approved INDICAID® COVID-19 Rapid Antigen Test for commercialisation as part of the country's efforts in controlling recent spikes of COVID-19 cases in the region.
Hong Kong, S.A.R., China government endorses INDICAID(R) in visitation resumption arrangements prnasia
May 10, 2021
COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong, S.A.R., China biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitati